These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prostate specific antigen. Med Lett Drugs Ther; 1992 Oct; 34(880):93-4. PubMed ID: 1381807 [No Abstract] [Full Text] [Related]
3. Digital rectal examination-associated alterations in serum prostate-specific antigen. Gillenwater JY Am J Clin Pathol; 1992 Apr; 97(4):466-7. PubMed ID: 1372786 [No Abstract] [Full Text] [Related]
4. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer. Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860 [TBL] [Abstract][Full Text] [Related]
5. Comments on the article "Biomarkers for prostate cancer" by Eric Schiffer. Marshall S World J Urol; 2009 Aug; 27(4):577-8. PubMed ID: 19543735 [No Abstract] [Full Text] [Related]
6. [Usefulness of bone gammagraphy versus tumor markers (PSA/PAP) in monitoring cancer of the prostate]. Morote J; de Torres JA Actas Urol Esp; 1990; 14(4):268-70. PubMed ID: 1702258 [TBL] [Abstract][Full Text] [Related]
7. Re: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. McVary KT; Rademaker AW J Urol; 1990 Dec; 144(6):1485-6. PubMed ID: 1700159 [No Abstract] [Full Text] [Related]
8. Diagnosis of prostate cancer: a personal view. Stamey TA J Urol; 1992 Mar; 147(3 Pt 2):830-2. PubMed ID: 1371556 [No Abstract] [Full Text] [Related]
9. Prostate specific antigen in diagnosis, staging, and follow-up of prostate cancer. Cooper EH Prostate Suppl; 1992; 4():125-8. PubMed ID: 1374175 [No Abstract] [Full Text] [Related]
11. Early prostate cancer antigen-2: a controversial prostate cancer biomarker? Diamandis EP Clin Chem; 2010 Apr; 56(4):542-4. PubMed ID: 20167690 [No Abstract] [Full Text] [Related]
12. Tumour markers in monitoring the treatment of advanced prostate cancer. Cooper EH; Armitage TG Prog Clin Biol Res; 1990; 359():65-72; discussion 73-4. PubMed ID: 1704634 [No Abstract] [Full Text] [Related]
13. Prognostic significance of prostate specific antigen in endocrine treatment for prostatic cancer. Arai Y; Yoshiki T; Yoshida O J Urol; 1990 Dec; 144(6):1415-9. PubMed ID: 1700155 [TBL] [Abstract][Full Text] [Related]
14. Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men. Taneja SS J Urol; 2015 Jan; 193(1):127. PubMed ID: 25523657 [No Abstract] [Full Text] [Related]
15. Prostate antigen. A new perception of use in serum. Griffiths J Am J Clin Pathol; 1989 Dec; 92(6):845-6. PubMed ID: 2480063 [No Abstract] [Full Text] [Related]
16. Value of prostate-specific antigen measurements in predicting lymph node involvement in prostatic cancer. Arai Y; Yoshiki T; Yamabe H; Yoshida O Urol Int; 1990; 45(6):356-60. PubMed ID: 1705062 [TBL] [Abstract][Full Text] [Related]